Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Ramipril × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Cisplatin 247 Radiotherapy 205 Fluorouracil 174 Cyclophosphamide 167 Capecitabine 167 Docetaxel 146 Oxaliplatin 143 Gemcitabine 136 Carboplatin 131 Paclitaxel 130 Dexamethasone 110 Leucovorin 104 Drug Therapy 102 Doxorubicin 99 Etoposide 84 Cytarabine 76 Bevacizumab 75 Vincristine 73 Irinotecan 67 Rituximab 65 Epirubicin 63 Prednisone 57 Methotrexate 56 Radiosurgery 52 Surgical Procedures, Operative 51 Radiation 51 Radiotherapy, Intensity-Modulated 50 Neoadjuvant Therapy 48 Lenalidomide 48 Chemotherapy, Adjuvant 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02236806 2022-02-01

SAFE

Azienda Ospedaliero-Universitaria Careggi

Phase 3 Unknown

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡